Our Private Equity Group provides trusted counsel derived from deep industry knowledge to established as well as up-and-coming private equity firms. We represent firms of every size across the spectrum of investment strategies, and we build long-standing relationships with our clients. As active participants in the private equity industry, we are able to advise our clients on the latest innovations, as well as current market practices and trends.
eviCore to Be Acquired by Express Scripts for $3.6 Billion
- Client News
- October 10, 2017
As reported by Bloomberg, The Washington Post and other media outlets, Paul, Weiss is representing eviCore healthcare in its $3.6 billion acquisition by Express Scripts Holding Company. Express Scripts is acquiring eviCore from current investors, including General Atlantic, TA Associates and Ridgemont Equity Partners. The transaction, expected to close in the fourth quarter of 2017, is subject to customary regulatory approvals and closing conditions. eviCore is the industry leader in evidence-based medical benefit management services; Express Scripts provides integrated pharmacy benefit management services.
The Paul, Weiss team included, among others, corporate partners Matthew Abbott, Ellen Ching, Dale Sarro and John Kennedy and counsel Scott Grader and Pearl Yuan-Garg; employee benefits partner Robert Fleder and counsel Uri Horowitz; tax partners Patrick Karsnitz, David Mayo and David Sicular; litigation partner Allan Arffa; real estate partner Peter Fisch; intellectual property partner Claudine Meredith-Goujon; environmental counsel William O’Brien; and antitrust counsel Marta Kelly.